[1]
2025. Momelotinib Usage Within Our Current Canadian Myelofibrosis Armamentarium. Canadian Hematology Today. 4, s02 (Mar. 2025), 2–10. DOI:https://doi.org/10.58931/cht.2025.4s0262.